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Key summary points
Aim It is crucial to identify factors contributing to malnutrition risk in older persons in order to prevent malnutrition as far as possible.
Findings Factors that increased the risk of malnutrition were: increased levels of IL-8, osteoprotegerin (OPG), and Soluble-
Receptor-For-TNF-alfa (sTNFRII; log transformed). In comparison with previous studies, in our study there was no significant 
difference in hsCRP and IL-6 in participants at risk of malnutrition and those who were well-nourished, nevertheless, those 
at risk of malnutrition had significantly higher IL-8, OPG and sTNFRII concentrations, but higher levels of IL-18.
Message The etiopathogenesis of malnutrition in older persons is complex and our study indicated that chronic inflamma-
tion plays a probable role and should be considered in evaluating nutritional status in the geriatric population; however, it also 
exposes an avenue where further research is needed in order to enhance our understanding and guide comprehensive patient care.
Abstract
Purpose Malnutrition is an underestimated, but significant problem among older persons. It is described as a consequence 
of genetic and environmental factors, lack of physical activity, and co-morbidities. However, a key role of a geriatrician is to 
further explore the multidimensional complexity of this issue. The aim of this study was to identify the relationship between 
nutritional status and different factors, particularly focusing on inflammatory biomarkers.
Methods Nutritional status was assessed using Mini-Nutritional-Assessment with a score below 24 (out of 30) defined as 
malnutrition. Different serum biomarkers of inflammation were measured, such as High-Sensitivity-C-Reactive-Protein 
(hsCRP), Interleukin-6 (IL-6), Interleukin-8 (IL-8), Interleukin-18(IL-18), osteoprotegerin(OPG), and Soluble-Receptor-
For-TNF-alfa(sTNFRII). Medical history, mental status (Mini-Mental-State-Examination, Geriatric-Depression-Scale) and 
activities of daily living (using Instrumental-Activities-of-Daily-Living-Scale) were used in the evaluation. The relationship 
between nutritional status and the factors listed was assessed.
Results The mean age of 76 examined persons (40.8% female) from the outpatient clinic was 71 years. Malnutrition risk 
was recognized in 29%. The following factors significant in univariate regression were used in stepwise regression analysis: 
age, sex, mental status (MMSE, GDS), valve disease, number of diseases, IADL. Stepwise regression revealed that the risk 
of malnutrition was increased by the presence of valve disease, number of diseases, and female sex. Factors that increased 
the risk of malnutrition were: logsTNFRII (OR = 3.09; 95% CI 1.07–8.96), IL-8 (OR = 1.09; 95% CI 1.00–1.18), and OPG 
(OR = 1.27; 95% CI 1.02–1.57). Risk of malnutrition was negatively associated with Il-18(OR = 0.995; 95% CI 0.991–0.999).
Conclusions Chronic inflammation and immunologic process are likely contributors to the complex etiopathogenesis of 
malnutrition in older persons.
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Introduction
Nutrition plays a pivotal role in life. Although the vast 
majority of nutrition-focused efforts are dedicated to the 
epidemic of obesity, on the other end of the spectrum, mal-
nutrition is a significant problem posing increasing concern 
in our geriatric population. The term “malnutrition” is used 
to describe a host of nutritional abnormalities. Typically, it 
refers to protein–energy malnutrition that occurs when met-
abolic requirements chronically exceed nutritional intake, 
resulting in a longstanding negative balance of both energy 
and protein [1]. According to the Global Leadership Ini-
tiative on Malnutrition (GLIM) that was convened in Janu-
ary 2019, for establishing the diagnosis of malnutrition the 
combination of at least one phenotypic and one etiologic 
criterion is required [2]. To be more detailed, phenotypic 
criteria are as follows: non-volitional weight loss, low body 
mass index, reduced muscle mass. In addition to this, etio-
logic criteria include reduced food intake or assimilation and 
disease burden/inflammatory condition. Nevertheless, the 
recommended GLIM approach uses only phenotypic criteria 
cut-points to provide for severity grading [2].
Severe malnutrition leads to cachexia, a complex met-
abolic syndrome associated with underlying illness and 
inflammation which contributes to increased catabolism 
and increased muscle protein breakdown. It is character-
ized by loss of muscle with or without loss of fat mass. The 
prominent clinical feature of cachexia is weight loss in adults 
(corrected for fluid retention) or growth failure in children 
(excluding endocrine disorders) [3]. Cachexia is usually 
associated with severe illness and the rate of change in the 
form of weight loss and muscle wasting occurs much more 
rapidly than in age-related and disease-related muscle loss 
[4].
It is recommended that the GLIM consensus criteria 
should be applied to diagnose malnutrition in persons with 
sarcopenia, cachexia and frailty so that the priority to under-
take appropriate nutrition interventions may be recognized.
The important issue is that malnutrition is a risk factor for 
increased morbidity and decreased quality of life [5–7]. Its 
presence extends the duration of treatment and hospitaliza-
tion, increases the cost of treatment, the risk of disability and 
dependency, as well as mortality [8–11]. Many factors con-
tribute to the occurrence of malnutrition including co- and 
multi-morbidity, medications used, disability, and psychoso-
cial factors; including loneliness, poverty, and the aging pro-
cess itself. The aging process is accompanied by physiologic 
changes leading to the reduction of appetite, gastrointestinal 
motility disorders, decreased level of anabolic hormones, 
and dysregulation of the immune system. The effect of these 
changes is the increase in body weight in early old age asso-
ciated with a decrease in lean body mass and simultaneous 
increase in body fat. After the stabilization period, a weight 
loss of 1–2 kg is observed in each subsequent decade, with 
a reduction in the weight of both tissues in late old age. 
Inflammaging, a state of chronic moderate inflammation, is 
a factor that may contribute to loss of appetite, inhibition of 
albumin production, and weight loss. It is characterized by 
increased levels of pro-inflammatory cytokines, especially 
interleukin 6 (IL-6) and tumor necrosis factor-alfa (TNFα).
Increasing evidence from basic biological studies sug-
gests that inflammatory cytokines play a direct role in the 
development of typical manifestation of aging, such as sar-
copenia, anaemia, and cognitive decline. Higher levels of 
pro-inflammatory cytokines were found in the majority of 
older people, also in the absence of clinically active diseases 
[12] and without signs of infections [13]. Moreover, they 
are associated with clinical progression of chronic disease 
states. Increased levels of high sensitive C-reactive protein 
(hsCRP), TNFα and its soluble receptors, IL-6, IL-1, IL-8, 
IL-18 were found in different chronic conditions such as 
atherosclerosis, cardiovascular disease, chronic heart fail-
ure (CHF), diabetes, chronic obstructive pulmonary disease, 
chronic kidney disease, and cancer. Also osteoprotegerin 
(OPG), a member of TNFα receptor superfamily turned 
out to be a predictor of complications, cardiovascular risk, 
and of poor prognosis in many chronic conditions [14–17]. 
Increased level of OPG was predictive of hospitalization for 
heart failure in patients with advanced systolic CHF and 
ischemic heart disease independently of conventional risk 
markers [16].
Nonetheless, there is an evidence of a relationship 
between malnutrition and inflammation expressed by ele-
vated levels of pro-inflammatory cytokines and these bio-
markers were independent risk factors of malnutrition in 
various disease states, such as renal failure [18], neoplastic 
disease [19], and Alzheimer’s disease [20].
Many laboratory indicators are used to assess malnutri-
tion and its risk. Abd-Elraheem et al. stated that among dif-
ferent factors like serum levels of albumin, transferrin, total 
cholesterol, vitamin D, and lymphocyte count, low serum 
albumin levels best predict 1-year mortality in hospitalized 
older adults, followed by low transferrin serum levels [21]. 
But described independent relationships between malnutri-
tion and inflammatory markers indicate that there exists a 
need for further investigation of the link between malnutri-
tion and inflammation in old age.
For that reason the aim of this study was to identify the 
relationship between nutritional status and different factors, 
particularly focusing on inflammatory biomarkers in older 
patients.
Because pro-inflammatory cytokines are involved in both, 
ageing and chronic conditions, from among many inflam-
matory markers we decided to assess those explored earlier 
(hsCRP, IL-6), and those involved in the development of 
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chronic diseases and its complications, especially cardio-
vascular diseases often occurring in older people, but less 
frequently studied in the context of malnutrition, like OPG, 
IL-18, soluble receptor II for TNFα (sTNFRII).
Patients and methods
Study design and patient enrollment
A cross-sectional study design was utilized. Patients aged 
60 years or older followed in the Geriatric Outpatient Clinic 
were included from October 2010 to February 2014. All 
individuals signed an informed consent to participate in the 
study.
The most significant exclusion criterion was active 
inflammatory state or exacerbation of chronic inflammation/
chronic condition, another exclusion criteria were: immobil-
ity, Mini-Mental State Examination (MMSE) score below 10 
and if the patient had dementia or cognitive impairment, the 
interview was completed by a proxy. It is worth noting that 
all participants came to the clinic for routine checks inde-
pendently in the stable period of the disease. In all patients, 
demographic data, smoking status, past/current medical his-
tory, and medication history were obtained using a struc-
tured questionnaire. The obtained data from questionnaires 
was supplemented with information from medical records. 
Weight (kg) and height (m) were measured and BMI (kg/
m2) was calculated according to the formula: weight (kg)/
(height (m))2.
Cognitive function was assessed using the MMSE, in 
which a score below 24 of 30 suggested cognitive impair-
ment. Mood was assessed with the 30-point Geriatric 
Depression Scale (GDS), in which a score of 11 points and 
higher suggested depression.
The risk of malnutrition was evaluated using the Mini 
Nutritional Assessment (MNA) with a maximum score of 
30 points; 24 points and higher suggested normal nutritional 
status, 17–23.5 points suggested an increased risk of mal-
nutrition, and below 17 points suggested malnutrition. In 
our sample, the minimum MNA score was 18.5; therefore, 
the MNA score of less than 24 was used as a categorical 
variable.
Functional status was assessed by the Instrumental Activ-
ities of Daily Living (IADL) scale with a maximum score 
of 27 points. The higher the score, the better the functional 
status.
Handgrip strength was measured with hydraulic hand 
dynamometer Model SH5001, SEAHEN Corp. MASAN 
Korea.
Muscle mass including total lean body mass (LBM), 
and appendicular lean mass (aLM) was examined using a 
dual-energy X-ray absorptiometry (DXA) (Lunar Prodigy, 
General Electric Medical Systems).
Human interleukin immunoassay kits were used to assess 
serum IL-6 and interleukin-8 (IL-8) levels including Human 
IL-6 immunoassay  Quantikine® HS ELISA and Human 
CXCL8/IL-8 Immunoassay  Quantikine® ELISA (R&D 
Systems, Inc., 614 McKinley Place NE, Minneapolis, MN 
55413, USA). Serum IL-18 level was measured by Human 
IL-18 ELISA Kit (Medical & Biological Laboratories CO., 
Japan). For the quantitative measurement of sTNFRII serum 
concentrations, Human TNFRII/TNFRSF1B Immunoassay 
 Quantikine® ELISA (R&D Systems, Inc. 614 McKinley 
Place NE, Minneapolis, MN 55413, USA) was used. Osteo-
protegerin (OPG) concentration was determined using sand-
wich enzyme immunoassay, the RD194003200 Human Oste-
oprotegerin ELISA kit (BioVendor – Laboratorni medicina 
a.s. Karasek 1767/1, 621 00 Brno, Czech Republic).
The study was approved by the Bioethical Committee of 
Jagiellonian University (Kraków, Poland).
Statistical analysis
Due to the relatively small sample size of the study sub-
groups as well as the non-normal distribution of variables, 
the descriptive characteristics were presented as medians 
and interquartile range (IQR) for continuous variables and 
number and relative frequency for nominal data. The two 
study groups, “risk of malnutrition” and “no risk of mal-
nutrition”, were compared with U Mann–Whitney test and 

2 test, respectively. The relationship between qualitative 
variables was assessed by Spearman’s rank correlation coef-
ficient. Binary logistic stepwise regression model, with the 
risk of malnutrition as the dependent variable, was used to 
assess the characteristics related to the risk of malnutrition. 
The initial set of independent variables used in each model 
was as follows: age, sex, valve disease, number of diseases, 
GDS, MMSE, IADL, and inflammatory biomarkers. The p 
value was set at 0.05 for entering variables in the logistic 
regression model in a stepwise procedure. The results were 
expressed as Odds Ratio (OR) together with 95% confi-
dence intervals (95% CI). The statistical analysis was carried 
out in STATA/SE 14 (Stata Corp, College Station, Texas, 
United States). In all analyses, 2-sided tests were used. p 
values < 0.05 were considered significant.
Results
Mean age (IQR of 76 participants; 40.8% female) was 
71 years (67; 76.5). The most common disease was hyper-
tension followed by coronary heart disease (CHD), chronic 
heart failure (CHF), osteoarthrosis, history of myocardial 
infarction (MI), and diabetes. A quarter of the patients were 
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diagnosed with valve disease, mainly mitral insufficiency 
developed in the course of CHD and heart failure. Those, 
with valve disease had more advanced heart failure in the 
form of a lower ejection fraction (data not shown). We 
divided the examined persons into two groups: the group 
without the risk of malnutrition (according to the MNA 
score ≥ 24) and the group at risk of malnutrition (with MNA 
score < 24). These groups did not differ in terms of age, sex, 
smoking history, BMI, number of diseases, number of medi-
cations, the presence of diseases (i.e. CHF, CHD, MI, stroke, 
diabetes mellitus, hypertension, osteoarthrosis), MMSE 
score, GDS score, or IADL score. Furthermore, there was 
no significant difference in muscle mass between well-nour-
ished and patients at risk of malnutrition. Nevertheless, the 
groups varied by the presence of valve disease (Table 1).
Laboratory results were significant for a lower level of 
hemoglobin in the group at risk for malnutrition. There was 
no significant difference in albumin and creatinine concen-
tration between the two groups. There was also a signifi-
cant difference in levels of OPG and sTNFRII between the 
two study groups, with higher levels found in the group at 
risk for malnutrition. There was no significant difference in 
hsCRP, IL-6, IL-8, and IL-18 levels (Table 2).
Bearing in mind the relationship between chronic dis-
eases and inflammation, we assessed the relationship 
between inflammatory markers and possible measurable 
indicators of disease advancement, which might contribute 
to malnutrition. We found negative correlations between 
estimated glomerular filtration rate (eGFR) calculated 
according to Modification of Diet in Renal Disease 
(MDRD) and IL-6 (  = − 0.39, p = 0.006), and sTNFRII 
(  = − 0.61, p < 0.0001), positive correlation between IL-18 
and creatinine level (  = 0.36, p = 0.01), and OPG (  = 0.34, 
p = 0.02), but no patient had severe kidney failure. Asso-
ciation also was found between inflammatory bio-markers 
and indicator of heart failure –NT-proBNP. NT-proBNP 
positively correlated with IL-6 (  = 0.40, p = 0.005), hsCRP 
(  = 0.30, p = 0.04), OPG (  = 0.45, p = 0.002), and with 
sTNFRII (  = 0.42, p = 0.003). Negative correlations were 
also shown between high-density cholesterol (HDL) and 
IL-6 (  = − 0.30, p = 0.03), IL-18 (  = − 0.53, p = 0.0001), 
hsCRP (  = − 0.34, p = 0.02), OPG (  = − 0.35, p 0.02), 
and sTNFRII (  = − 0.33, p = 0.02). Importantly, in assess-
ing the risk of malnutrition, a negative correlation was 
found between albumin and IL-6 (  = − 0.48, p = 0.0005) 
and hsCRP (  = − 0.32, p = 0.03). Despite the correlations 
shown, that may indicate a relationship between inflamma-
tion and disease progression (chronic kidney disease, heart 
failure, dyslipidemia), none of these diseases has been asso-
ciated with the risk of malnutrition in a univariate regression 
analysis. Only valve disease that may indicate an advanced 
form of heart failure was significantly associated with the 
Table 1  The characteristics of study group
BMI body mass index, CHF chronic heart failure, CHD coronary heart disease, GDS Geriatric Depression Scale, IADL Instrumental Activities 
of Daily Living, IQR interquartile range, MI myocardial infarction, MMSE Mini-Mental State Examination
Variable All (n = 76) MNA ≥ 24 (n = 54) MNA < 24 (n = 22) p value
Age (years) (median; IQR) 71 [67; 76.5] 70.5 [67; 76] 71.5 [69; 77] 0.17
Sex (female; %) 40.8 35.2 54.6 0.12
Smokers (%) 11.8 12.9 9.1 0.63
Pack-years (median; IQR) 0 [0; 25] 0 [0; 25] 4.25 [0; 22.5] 0.78
BMI (kg/m2; median; IQR) 28.1 [25.9; 30.9] 28.7 [26.4; 31.3] 26.53 [24.8; 29.7] 0.06
Number of diseases (median; IQR) 5 [4; 7] 5 [4; 6] 6 [4; 7] 0.06
Number of medications (median; IQR) 7 [6; 9] 7 [6; 9] 7 [6; 9] 0.87
CHF (%) 69.7 66.7 77.3 0.36
CHD (%) 73.7 74.1 72.3 0.90
MI (%) 46.1 46.3 45.5 0.95
Stroke (%) 7.9 7.4 9.1 0.80
Diabetes (%) 39.5 35.2 50.0 0.23
Hypertension (%) 89.5 92.6 81.8 0.16
Valve disease (%) 25.0 16.7 45.5 0.01
Osteoarthrosis (%) 59.2 54.0 22.0 0.98
MMSE (median; IQR) 28 [25; 29] 28 [25; 29] 26.5 [25; 28] 0.10
GDS (median; IQR) 8 [6; 14] 8 [6; 14] 9 [7; 16] 0.21
Handgrip strength (kg) (median; IQR) 20 [12; 28] 20 [12.6; 28] 15.3 [10; 22] 0.04
Lean body mass (kg) 49.2 [40.8; 54.1] 49.4 [42.2; 54.2] 44.9 [39.0; 54.0] 0.26
Appendicular muscle mass (kg) 21.1 [16.4; 23.9] 21.2 [17; 23.5] 18.3 [15.8; 24.3] 0.46
aLM/BMI 0.74 [0.58; 0.81] 0.75 [0.58; 0.81] 0.70 [0.61; 0.84] 0.95
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risk of malnutrition in a univariate analysis, which is why 
its presence was included in the final regression models.
In the context of assessing risk of malnutrition and 
potential contribution of advanced heart failure it is worth 
emphasizing that patients with heart failure had higher 
total muscle mass (49.04  kg vs 41.77  kg, p < 0.001) 
and appendicular muscle mass standardized for height 
(7.48 kg/m2 vs 6.92 kg/m2, p = 0.03) as well as greater 
muscle strength (19 [12.35; 29] kg vs 12 [9;17] kg, 
p < 0.001] compared to people without heart failure, which 
may indicate a lack of cardiac cachexia in HF patients 
and suggest the contribution of other factors to the risk 
of malnutrition.
In a stepwise regression analysis, malnutrition served 
as the dependent variable. A set of potentially contributing 
factors (significant in a univariate regression analysis) and 
inflammatory biomarkers were separately introduced to the 
models. The analysis revealed that the risk of malnutrition 
increased with a higher number of comorbidities, female 
sex, cognitive impairment, and inflammation measured by 
a higher concentration of IL-8, logsTNFRII, and OPG; the 
risk of malnutrition was negatively associated with Il-18 
level (Tables 3, 4, 5, and 6).
Based on the logistic regression results, higher levels of 
OPG, IL-8, and sTNFRII were independent predictors of 
malnutrition risk. Increase of OPG by one [pmol/l] resulted 
in OR = 1.27 (95% CI 1.022–1.57); increase of IL-8 by one 
[pg/ml] resulted in OR = 1.09 (95% CI 1.003–1.18); odds of 
malnutrition increased more than three-fold per each log-
sTNFRII (OR = 3.09 95% CI 1.07–8.96). An inverse rela-
tionship was observed between IL-18 level and malnutrition 
risk; per increase of IL-18 by one [pg/ml], odds of malnutri-
tion decreased by 0.5% (95% CI 0.991–0.999).
Table 2  The laboratory tests result in the study group, the whole and according to nutrition status
hsCRP high sensitive C reactive protein, IL-6 interleukin 6, IL-8 interleukin 8, IL-18 interleukin 18, IQR interquartile range, sTNFRII soluble 
tumor necrosis factor-α receptor type II
Variable All (n = 76) MNA ≥ 24 (n = 54) MNA < 24 (n = 22) P
Creatinine (µmol/L; median; IQR) 86.1 [62.7; 102.5] 85.8 [68; 102.9] 88.45 [66.4; 102] 0.62
Hemoglobin (g/dL; median; IQR) 13.7 [12.9; 14.7] 13.9 [13.2; 15] 12.9 [12.3; 13.3]  < 0.001
Albumin (g/L; median; IQR) 43.0 [41; 45] 43 [41; 45] 42 [40; 44] 0.07
hsCRP (mg/L; median; IQR) 1.65 [0.77; 3.56] 1.76 [0.79; 3.29] 1.46 [0.57; 6.53] 0.99
IL-6 (pg/ml; median; IQR) 3.61 [2.33; 5.46] 3.61 [2.31; 5.37] 3.51 [2.68; 6.28] 0.57
Osteoprotegerin (pmol/l; median; IQR) 7.53 [6.2; 10.1] 7.22 [6.13; 8.97] 9.52 [6.4; 11.37] 0.04
IL-8 (pg/ml; median; IQR) 11.61 [7.82; 19.68] 11.03 [7.83; 15.98] 13.97 [7.82; 23.48] 0.42
IL-18 (pg/ml; median; IQR) 414.7 [301.5; 507.6] 437.5 [316.7; 556.8] 360.8 [257.4; 455.7] 0.08
sTNFRII (pg/ml; median) 3102 [1978.5; 3901] 2781 [1659; 3701] 3474.5 [2791; 4176] 0.048
Table 3  The stepwise logistic regression analysis with IL-8 level as 
the independent variable
Malnutrition risk Odds ratio 95% CI P
Valve disease 9.14 1.55; 53.82 0.01
Sex (Male) 0.04 0.01; 0.36 0.004
Number of diseases 1.74 1.09; 2.77 0.02
IL-8 (pg/ml; median; IQR) 1.09 1.00; 1.18 0.04
MMSE (points) 0.76 0.59; 0.98 0.03
Table 4  The stepwise logistic regression analysis with logsTNFRII as 
the independent variable
Malnutrition risk Odds ratio 95% CI P
Valve disease 4.80 1.23; 18.82 0.02
Sex (Male) 0.13 0.03; 0.55 0.01
Number of diseases 1.47 1.07; 2.01 0.02
logsTNFRII (median; IQR) 3.09 1.07; 8.96 0.04
Table 5  The stepwise logistic regression analysis with osteoprote-
gerin as the independent variable
Malnutrition risk Odds ratio 95% CI P
Valve disease 4.24 1.12; 16.11 0.03
Sex (Male) 0.12 0.03; 0.53 0.005
Number of diseases 1.44 1.06; 1.95 0.002
OPG (pmol/l; median; IQR) 1.27 1.02; 1.57 0.03
Table 6  The stepwise logistic regression analysis with IL-18 as the 
independent variable
Malnutrition risk Odds ratio 95% CI P
Valve disease 7.56 1.73; 33.0 0.01
Sex (Male) 0.19 0.05; 0.80 0.02
Number of diseases 1.54 1.12; 2.12 0.01
IL-18 (pg/ml; median; IQR) 0.995 0.991; 0.999 0.047
MMSE (points.) 0.84 0.69; 1.03 0.09
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Discussion
In our study population, the risk of malnutrition was associ-
ated with female sex, presence of valve disease, and multi-
ple co-morbidities. Factors that increased the risk of mal-
nutrition were: increased levels of IL-8, OPG, and sTNFRII 
(log-transformed). The risk of malnutrition was negatively 
associated with Il-18 level. The obtained results indicate 
that irrespective of the etiology (inflammaging or related 
to chronic conditions), inflammation is associated with a 
greater risk of malnutrition.
Although chronic diseases may lead to cachexia most of 
our patients were not malnourished, but at risk of malnu-
trition. Because of a cross-sectional design of this study, 
we were not able to assess the potential loss of weight, but 
even in the group at risk of malnutrition median BMI was 
over 26 kg/m2 and both groups did not differ significantly 
in muscle mass.
Previous studies have demonstrated a relationship between 
malnutrition and elevated levels of IL-6 and TNFα [22, 23]. 
It is also known that high level of cytokines TNFα, IL-6, and 
IL-2 are associated with a decrease in food intake and may 
contribute to anorexia. Other studies have demonstrated the 
relationship between malnutrition and inflammatory markers 
in specific population groups, including in children [24, 25], 
dialysis patients [14, 15, 18, 26–30], patients with neoplasms 
[19, 31, 32], and patients with autoimmune diseases [33, 34].
Our study included an expanded panel of inflammatory 
biomarkers and assessed their association with risk of mal-
nutrition in a population of geriatric counseling patients. Oe 
et al. also studied a population of older persons, but located 
in Japan. Their study showed that TNFα was associated with 
inflammation and insulin resistance in both Japanese older 
men and women; a prominent association was observed 
between TNFα and malnutrition status in older women 
[35]. In another study, Singh et al. proposed that inflamma-
tion, especially expressed by elevated IL-6 levels, may be 
a common cause of multiple age-related diseases or a final 
common pathway by which disease leads to disability and 
adverse outcomes in older adults [36].
In a study of patients with end-stage renal disease, it was 
suggested that malnutrition was best predicted by hsCRP and 
IL-6 levels [18]. In our study, there was no significant differ-
ence in hsCRP and IL-6 in participants at risk of malnutri-
tion and those who were well-nourished; however negative 
correlations between hsCRP and IL-6 levels and albumin 
concentration were found, and those at risk of malnutrition 
had significantly higher IL-8 concentrations.
IL-8 is a small protein chemoattractant that recruits neu-
trophils to sites of inflammation through interaction with 
at least two types of receptors-A and B [37]. The level of 
IL-8 is important in evaluating several chronic diseases, 
such as diabetes, cancer, obesity, and autoimmune disease. 
Gioulbasanis et al. showed that baseline IL-8 levels correlate 
with the nutritional status of patients with metastatic non-
small-cell lung cancer patients (NSCLC), suggesting that 
this cytokine may be related to cachexia [19].
Additionally, Abo-Shousha et al. demonstrated that IL-6 
and IL-8 levels were higher in children with protein-energy 
malnutrition than in properly nourished children [25]. Suga-
wara et al. presented that there is a significant increase in the 
levels of IL-6 and IL-8 in malnourished patients with chronic 
obstructive pulmonary disease (COPD). The levels of elevated 
inflammatory cytokines decreased significantly post nutritional 
intervention combined with the low-intensity exercise [38].
Yoo et al. studied patients with sarcopenia, demonstrating 
that they had higher levels of CRP and erythrocyte sedimen-
tation rate (ESR) than his control group. Chronic inflamma-
tion, associated with increased degradation of muscle protein, 
was determined to be an important risk factor for hip fracture 
in sarcopenic patients [39]. In our study group of patients in 
a stable period of their diseases well-nourished patients and 
those at risk of malnutrition did not differ in muscle mass.
Further evidence of the relationship of malnutrition with 
inflammation is the study by Takele et al. who found a sig-
nificant correlation between low BMI and increased levels 
of IFN-γ, IL-2, IL-12, IL-4, IL-5, IL-13, IL-10, IL-33, and 
TNFα; however, not IL-8 or CRP. Their results show that 
even in the absence of apparent infections, healthy malnour-
ished individuals display dysfunctional immune responses 
which may cause increased susceptibility to infectious dis-
eases with more severe presentations [40].
As shown above, the presence of chronic diseases can 
contribute to increase of inflammatory marker levels, but 
increase of inflammatory cytokines was also observed in 
malnourished but healthy individuals [25, 40].
Moreover, van der Pols-Vijlbrief et al. in their systemic 
review found moderate evidence for no association between 
having a chronic disease and protein-energy malnutrition. 
In addition to this, strong evidence for no association was 
found for, among others, high number of diseases, stroke, 
heart failure and coronary failure [41].
TNFα is among the inflammatory markers frequently 
used to study processes of aging. It is primary produced 
by macrophages and plays a role in directing inflammatory 
reactions in our bodies by stimulating release of proteins, 
like IL-6 and CRP. TNFα is produced as an adipocytokine 
in adipose tissue. When adipose tissue expands to a great 
extent, TNFα contributes to insulin resistance [35]. Studies 
have demonstrated high levels of TNFα in correlation with 
decline in muscle mass/strength, suggesting an association 
with sarcopenia and malnutrition [42, 43].
The actions of TNFα are mediated by two distinct TNF 
receptors, receptors 1 and 2 (TNFRI and TNFRII). Our study 
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used TNFRII level as an inflammatory marker and it was 
determined to be higher in patients at risk of malnutrition.
As written above, Oe et al. observed a significant associa-
tion between TNFα and malnutrition status in older women 
[35]. In another study, high levels of circulating TNFα were 
observed in patients with Alzheimer’s disease experiencing 
unexplained weight loss [20]. Correia et al. further docu-
mented a significant direct correlation between higher levels 
of cytokines (especially TNFα), malnutrition, and decreased 
quality of life in patients with gastric cancer [31].
Another important biomarker is OPG, a member of the 
TNF receptor super-family, which we found to be associ-
ated with increased risk for malnutrition. OPG is secreted by 
osteoblasts, mesenchymal stem cells, fibroblasts, endothelial 
cells, and human adipose tissue [44]. It has pleiotropic effects 
over bone metabolism as well as endocrine function [45].
The role and significance of OPG seems to be broad 
and not fully understood. Krzanowski et al. postulated that 
OPG might be an early indicator of all-cause mortality in 
patients with chronic kidney disease and advanced medial 
arterial calcification [14]. Janda et al. found that elevated 
serum OPG levels may be useful as a prognostic marker of 
cardiovascular risk in dialyzed patients [15]. A higher OPG 
level predicts poor prognosis in subjects with heart failure, 
diabetes, end-stage kidney disease, coronary artery disease, 
acute coronary syndrome, and silent myocardial ischemia 
[16, 17]. Our results demonstrate association between higher 
level of OPG and risk of malnutrition in older persons.
In contrast to the biomarkers mentioned above, IL-18 
was associated with decreased risk of malnutrition in our 
study. IL-18 is an inflammatory cytokine, first identified by 
Okamura et al. in 1995. It is found in multiple cell types 
including immune, hematopoietic, chondrocytic, intestinal 
epithelial cells, astrocytes, and microglial cells. As a mem-
ber of the IL-1 family, IL-18 acts in synergy with IL-12 
to activate murine and human T-cells, thereby signaling 
induction of inflammation, interferon-gamma production, 
and cell-mediated immunity [46].
IL-18, together with IL-1β, serves in activation of down-
stream inflammation signaling in a state of infection and 
injury [47, 48]. Higher levels of IL-18 have also been meas-
ured in patients with ANCA-associated vasculitis and those 
undergoing hemodialysis [33]. Moreover, systemic juvenile 
idiopathic arthritis or adult-onset Still’s disease are also 
characterized by high serum IL-18 concentrations and are 
treated by IL-18BP (binding protein).[49]. IL18 seems to be 
important indicator and predictor of cardiovascular death in 
two-year follow-up among non-diabetic patients suffering 
from chronic kidney disease, with a history of acute myo-
cardial infarction in the previous year. The importance of 
IL-18 in the process of atherosclerotic plaque formation has 
been confirmed by systems analysis based on a formal model 
expressed in the language of Petri nets theory [50].
In addition to its role in autoimmune diseases, IL-18 con-
tributes to the process of atherosclerosis and, therefore, by 
inference to aging. Clearly, reducing IL-18 activities can be 
viewed as possible therapeutic strategies to slow the aging 
process [51]. It was shown that IL-18 as a proatherogenic 
cytokine was associated with the development of cardiovas-
cular disease and all-cause mortality in stable heart disease 
patients independent of cardiac dysfunctions [26]. It is a 
strong predictor of cardiovascular death in patients with sta-
ble or unstable angina [52].
Worth mentioning is fact, that one study demonstrated 
significantly decreased plasma IL-18 levels in patients with 
anorexia nervosa compared to controls. Plasma IL-18 levels 
directly correlated with BMI in controls, but not in patients with 
anorexia nervosa. These results suggest that a decline in plasma 
IL-18 levels in patients with anorexia nervosa is not only due to 
malnourishment, but other pathophysiologic changes as well. 
IL-18 has a role in brain’s reaction to sadness and chronic stress. 
Therefore, decreased levels of IL-18 may commonly occur in 
patients with chronic anorexia nervosa [46].
It is difficult to explain the lower IL-18 level in patients 
with malnutrition risk in comparison to the patients with 
proper nutrition. It might be a result of a relatively low num-
ber of participants. However, as an explanation, we should 
also take into account an appropriate treatment that causes 
the stability of the diseases, as evidenced by relatively good 
muscle mass in patients with heart failure.
An article published in November 2019 dedicated the 
MaNuEL Toolbox (2-year Joint Action Malnutrition in the 
Elderly project) shows how important is the problem of mal-
nutrition is in older people. It was made available to effec-
tively distribute and disseminate the MaNuEL results and 
recommendations, which will support researchers, healthcare 
professionals, policy-makers as well as educational institutes 
to advance their efforts in tackling the increasing problem 
of protein–energy malnutrition in the older population [53].
However, the authors of The MaNuEL Multicohort Meta-
Analysis focused on and stressed the importance of social 
and physical factors contributing to malnutrition of older 
people. According to its results unmarried, separated, or 
divorced participants were more likely to develop malnutri-
tion that married participants, whereas no association was 
found for widowed participants. Participants with difficulty 
in walking or difficulty in climbing stairs and those who 
were hospitalized before baseline and during follow-up had 
higher odds of incident malnutrition [54].
We are aware of some limitations of this study—first, the 
observational nature of the study does not allow to deter-
mine the causative relationship between malnutrition risk 
and inflammation process, this should be studied in depth 
later. The second, the number of patients included in this 
analysis is small and that limits the statistical power to detect 
differences between study groups, as well as do not allow for 
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studying many possible confounders that can play role in the 
association between malnutrition and inflammation. Another 
important consideration is the lack of participants diagnosed 
with malnutrition, which may weaken the significance of 
relationships assessed. In addition to this, the group is het-
erogeneous and, as previously was written, relatively small, 
so that might influence the results. Finally, we also took into 
consideration that the markers are of poor specificity.
Despite these limitations, our study points out that there 
is a relationship between inflammation and risk of malnutri-
tion in patients in stable period of chronic diseases. Besides, 
it extends a cytokine spectrum connected with unsatisfactory 
nutritional state.
In conclusion, the etiopathogenesis of malnutrition in 
older persons is complex.
Our study indicated that chronic inflammation, irre-
spective of the reason, plays a probable role and should be 
considered in evaluating nutritional status in the geriatric 
population; however, it also exposes an avenue where further 
research is needed in order to enhance our understanding and 
guide comprehensive patient care.
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